Li Wen

4.0k total citations · 1 hit paper
101 papers, 2.4k citations indexed

About

Li Wen is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Li Wen has authored 101 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Surgery, 28 papers in Molecular Biology and 27 papers in Oncology. Recurrent topics in Li Wen's work include Pancreatitis Pathology and Treatment (37 papers), Pancreatic and Hepatic Oncology Research (19 papers) and Pancreatic function and diabetes (10 papers). Li Wen is often cited by papers focused on Pancreatitis Pathology and Treatment (37 papers), Pancreatic and Hepatic Oncology Research (19 papers) and Pancreatic function and diabetes (10 papers). Li Wen collaborates with scholars based in China, United States and United Kingdom. Li Wen's co-authors include Sohail Z. Husain, Sebastian Vogt, Rabia Ramzan, Bernhard Kadenbach, Dae-Young Kim, Zhining Fan, Qiang Huang, Zibin Tian, Zhao‐Shen Li and Nonghua Lü and has published in prestigious journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Li Wen

92 papers receiving 2.4k citations

Hit Papers

Mitochondrial Dysfunction, Through Impaired Autophagy, Le... 2017 2026 2020 2023 2017 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Wen China 26 1.1k 702 639 568 240 101 2.4k
Nobuyuki Tanaka Japan 35 1.1k 1.0× 717 1.0× 604 0.9× 677 1.2× 269 1.1× 264 4.4k
Sunil J. Patel United States 29 686 0.6× 814 1.2× 262 0.4× 293 0.5× 470 2.0× 96 2.8k
Viktor E. Eysselein United States 33 1.1k 0.9× 817 1.2× 637 1.0× 325 0.6× 327 1.4× 123 3.4k
Jie Zhong China 28 577 0.5× 817 1.2× 253 0.4× 225 0.4× 312 1.3× 119 2.5k
David O’Regan United Kingdom 30 666 0.6× 758 1.1× 249 0.4× 296 0.5× 216 0.9× 94 2.8k
Mark Sullivan United Kingdom 33 723 0.6× 778 1.1× 191 0.3× 923 1.6× 182 0.8× 112 3.1k
Yupeng Liu China 28 414 0.4× 1.0k 1.4× 509 0.8× 254 0.4× 224 0.9× 173 2.7k
Ken‐ichi Aihara Japan 29 453 0.4× 813 1.2× 216 0.3× 296 0.5× 215 0.9× 117 2.8k
Takayuki Ando Japan 26 513 0.5× 1.3k 1.9× 388 0.6× 450 0.8× 199 0.8× 166 2.5k
Rui Tian China 23 356 0.3× 593 0.8× 372 0.6× 220 0.4× 158 0.7× 99 2.0k

Countries citing papers authored by Li Wen

Since Specialization
Citations

This map shows the geographic impact of Li Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Wen more than expected).

Fields of papers citing papers by Li Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Wen. The network helps show where Li Wen may publish in the future.

Co-authorship network of co-authors of Li Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Li Wen. A scholar is included among the top collaborators of Li Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Wen. Li Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Shiyu, Lu Yang, Lu Lu, et al.. (2025). Proteomic analysis of plasma and urine for efficacy prediction biomarkers of Janus kinase inhibitors combined with phototherapy in vitiligo. British Journal of Dermatology. 192(6). 1141–1143.
3.
Lai, Yamin, et al.. (2024). Rare cause of recurrent acute pancreatitis in teenage man. SHILAP Revista de lepidopterología. 2(3). e100105–e100105.
4.
Mei, Wentong, Xiuli Zhang, Mengya Niu, et al.. (2024). Deletion of myeloid-specific Orai1 calcium channel does not affect pancreatic tissue damage in experimental acute pancreatitis. Pancreatology. 24(4). 528–537. 2 indexed citations
5.
Huang, Yan, Na Jiang, Rui Wang, et al.. (2023). Time-Course Lipidomics of Ornithine-Induced Severe Acute Pancreatitis Model Reveals the Free Fatty Acids Centered Lipids Dysregulation Characteristics. Metabolites. 13(9). 993–993. 3 indexed citations
7.
Barakat, Monique T., Mang Yu, Ying Ding, et al.. (2022). A review of the rationale for the testing of the calcineurin inhibitor tacrolimus for post-ERCP pancreatitis prevention. Pancreatology. 22(6). 678–682. 6 indexed citations
8.
Ouyang, Yulin, Li Wen, J. A. Armstrong, et al.. (2021). Protective Effects of Necrostatin-1 in Acute Pancreatitis: Partial Involvement of Receptor Interacting Protein Kinase 1. Cells. 10(5). 1035–1035. 16 indexed citations
9.
Jiang, Zhongxin, Yining Wang, Zhihui Dai, et al.. (2021). The m6A mRNA demethylase FTO in granulosa cells retards FOS-dependent ovarian aging. Cell Death and Disease. 12(8). 744–744. 81 indexed citations
10.
Hernandez, Genaro, Ting Luo, Tanveer A. Javed, et al.. (2020). Pancreatitis is an FGF21-deficient state that is corrected by replacement therapy. Science Translational Medicine. 12(525). 34 indexed citations
11.
Zhou, Yue, Li Wang, Li Wen, et al.. (2020). Precision therapy of 6‐mercaptopurine in Chinese children with acute lymphoblastic leukaemia. British Journal of Clinical Pharmacology. 86(8). 1519–1527. 11 indexed citations
12.
Dong, Lei, Yilei Yang, Li Wang, et al.. (2019). Population Pharmacokinetics and Dosing Optimization of Imipenem in Children with Hematological Malignancies. Antimicrobial Agents and Chemotherapy. 63(6). 11 indexed citations
13.
Mukherjee, Amitava, Tanveer A. Javed, Li Wen, et al.. (2019). Asparagine Synthetase Is Highly Expressed at Baseline in the Pancreas Through Heightened PERK Signaling. Cellular and Molecular Gastroenterology and Hepatology. 9(1). 1–13. 15 indexed citations
14.
Wen, Li, Tanveer A. Javed, Dean Yimlamai, et al.. (2018). Transient High Pressure in Pancreatic Ducts Promotes Inflammation and Alters Tight Junctions via Calcineurin Signaling in Mice. Gastroenterology. 155(4). 1250–1263.e5. 52 indexed citations
15.
Hu, Cheng, Li Wen, Lihui Deng, et al.. (2017). The Differential Role of Human Cationic Trypsinogen (PRSS1) p.R122H Mutation in Hereditary and Nonhereditary Chronic Pancreatitis: A Systematic Review and Meta-Analysis. Gastroenterology Research and Practice. 2017. 1–7. 7 indexed citations
16.
Zhang, Rui, Li Wen, Yan Shen, et al.. (2016). One compound of saponins from Disocorea zingiberensis protected against experimental acute pancreatitis by preventing mitochondria-mediated necrosis. Scientific Reports. 6(1). 35965–35965. 10 indexed citations
17.
Wen, Li, Zhugen Yang, Wenyan Cui, & M D Li. (2016). Crucial roles of the CHRNB3–CHRNA6 gene cluster on chromosome 8 in nicotine dependence: update and subjects for future research. Translational Psychiatry. 6(6). e843–e843. 18 indexed citations
18.
Huang, Wei, Matthew C. Cane, Rajarshi Mukherjee, et al.. (2015). Caffeine protects against experimental acute pancreatitis by inhibition of inositol 1,4,5-trisphosphate receptor-mediated Ca 2+ release. Gut. 66(2). 301–313. 77 indexed citations
19.
Chen, Jianjun, et al.. (2014). Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years. European journal of medical research. 19(1). 26–26. 91 indexed citations
20.
Kadenbach, Bernhard, Rabia Ramzan, Li Wen, & Sebastian Vogt. (2009). New extension of the Mitchell Theory for oxidative phosphorylation in mitochondria of living organisms. Biochimica et Biophysica Acta (BBA) - General Subjects. 1800(3). 205–212. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026